Burning Rock Biotech Limited (BNR) Tops Q1 EPS by 13c; Offers Guidance
FREE Breaking News Alerts from StreetInsider.com!
StreetInsider.com Top Tickers, 11/1/2026
- Wall Street closes sharply lower as AI cash burn fears spark tech selloff
- Amazon burns cash, Intel flags weak PC demand as AI boom's costs ripple across markets
- Bitcoin, cryptocurrency prices fall after Binance reports security issue
- Higher yields now hurting AI stock bull as bond markets police capex: BofA
- Oil jumps 2%, settles at 6-month highs on fears of escalation in Iran
Tweet
Share
E-mailGet Alerts BNR Hot Sheet
Join SI Premium – FREE
(Updated - May 30, 2023 9:00 AM EDT)
Burning Rock Biotech Limited (NASDAQ: BNR) reported Q1 EPS of (RMB1.81), RMB0.13 better than the analyst estimate of (RMB1.94). Revenue for the quarter came in at RMB142.52 million versus the consensus estimate of RMB143 million.
2023 Financial Guidance
We reiterate our 2023 full-year revenue guidance of approximately 20% growth over 2022 vs. estimated growth of 20.1% Y/Y.
For earnings history and earnings-related data on Burning Rock Biotech Limited (BNR) click here.
Serious News for Serious Traders! Try StreetInsider.com Premium Free!
You May Also Be Interested In
- Evercose ISI downgrades Reddit, says monetization may not offset traffic weakness
- Oxford Square Capital Corp. (OXSQ) Misses Q3 EPS by 1c
- Gates Industrial Corporation plc (GTES) Tops Q3 EPS by 4c ; Offers Guidance
Create E-mail Alert Related Categories
Earnings, GuidanceRelated Entities
EarningsSign up for StreetInsider Free!
Receive full access to all new and archived articles, unlimited portfolio tracking, e-mail alerts, custom newswires and RSS feeds - and more!
